As AstraZeneca works to incorporate Alexion following ... the U.K. drugmaker unveiled a $360 million investment at Alexion's campus in Dublin, where it'll construct an API facility for small ...

head of AstraZeneca's operations and IT. The planned investment in Dublin is expected to support late-stage development and early commercial supply, the company said, adding that the site can be ...

Anglo-Swedish group AstraZeneca plans to have its first manufacturing base in Ireland operational in Dublin by 2025 in a further boost to the country’s life sciences sector. Companies like Hines ...

AstraZeneca’s chief executive said the U.K.’s “discouraging” tax rate was behind the company’s decision to build a $400 million API facility at the former Alexion campus in Dublin.

AstraZeneca unveiled plans for the Dublin facility in September 2021 with what was then a €337M price tag for construction of an API facility for small molecules. The site will also help the UK ...